Stockscreener 앱 받기
1.37
0.71%
-0.03
시간 외 거래:
1.39
0.02
+1.46%
전일 마감가:
$1.40
열려 있는:
$1.38
하루 거래량:
26,732
Relative Volume:
0.51
시가총액:
$7.81M
수익:
-
순이익/손실:
$-24.47M
주가수익비율:
-1.398
EPS:
-0.98
순현금흐름:
$-24.56M
1주 성능:
-17.26%
1개월 성능:
-45.28%
6개월 성능:
-61.06%
1년 성능:
-82.70%
1일 변동 폭
$1.30
$1.4806
1주일 범위
$1.28
$1.80
52주 변동 폭
$1.28
$13.61
에바종 바이오테크 Stock (EVAX) Company Profile
EVAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| EVAX | 1.37 | 7.81M | 0 | -24.47M | -24.56M | -0.98 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
에바종 바이오테크 주식(EVAX)의 최신 뉴스
Evaxion Biotech stock hits 52-week low at $1.31 - Investing.com
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower - MSN
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Fall in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week - MSN
Evaxion appeals Nasdaq delisting determination - Investing.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply Friday, Up 2.7% for Week - MSN
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1 - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Evaxion Biotech Reports Q3 Progress and Financials - TipRanks
European Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5% - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Friday - MSN
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN
Evaxion reports improved AI vaccine target predictions - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN
Evaxion Biotech A/S ADR (EVAX) Stock: From Low to High in 52 Weeks - The InvestChronicle
EVAX’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Evaxion Biotech inks vaccine licensing deal with MSD - Investing.com
Evaxion stock jumps on expanded vaccine development pact with MSD (NASDAQ:EVAX) - Seeking Alpha
H.C. Wainwright keeps buy rating on Evaxion stock, cites promising AI-powered cancer vaccine - Investing.com
Evaxion Biotech enhances AI vaccine discovery platform - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN
Evaxion reports promising phase 2 trial results for cancer vaccine - Investing.com
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - MSN
Evaxion reports high response rate in melanoma trial - Investing.com
Evaxion reports breakthrough in gonorrhea vaccine research - Investing.com
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading - MSN
Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com India
Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now - MSN
European Equities Traded in the US as American Depositary Receipts Move Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Down 4% - MSN
에바종 바이오테크 (EVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
3.56%
자본화:
|
볼륨(24시간):